Schena F P, Pannarale G, Carbonara M C
Institute of Nephrology, University of Bari, Polyclinic, Italy.
Nephrol Dial Transplant. 1996;11 Suppl 9:63-8. doi: 10.1093/ndt/11.supp9.63.
Renal amyloidosis is not a frequent disease: its annual frequency is approximately 2.5-2.8% of all renal biopsies. Individual cases are normally rare and for this reason clinical findings and therapeutic results obtained by clinical multicentre studies are well considered. This review describes the clinical and therapeutic aspects of renal amyloidosis and refers particularly to the results obtained by the Italian Study Group for renal amyloidosis and by the multicentre Italian study protocol for AL amyloidosis.
其年发病率约占所有肾活检病例的2.5 - 2.8%。个别病例通常较为罕见，因此临床多中心研究得出的临床发现和治疗结果具有重要参考价值。本综述描述了肾淀粉样变性的临床和治疗方面，尤其提及了意大利肾淀粉样变性研究组以及意大利关于AL淀粉样变性的多中心研究方案所取得的成果。
